Semaglutide
Wegovy is a prescription weight-management medicine containing semaglutide, a GLP-1 receptor agonist. It is prescribed only after a clinical assessment and used as part of a supervised plan with regular follow-up.
Semaglutide belongs to a class of medicines that mimic GLP-1, a hormone the gut releases after eating. Wegovy is the presentation of semaglutide intended for weight management, and it is designed to be used within a structured programme rather than on its own.
Treatment is introduced gradually. The clinician reviews how you are tolerating it, whether it is helping, and whether to continue, adjust or stop. Nutrition, activity and follow-up remain central throughout — the medicine supports a plan, it does not replace one.
A consultation exists to work out whether this is a reasonable option for you. It may not be, and saying so is part of the clinician's job.
GLP-1 is released by the gut in response to food and takes part in signalling to the brain and digestive system about having eaten.
A GLP-1 receptor agonist activates the same receptor, influencing appetite signalling and the rate at which the stomach empties. People commonly describe feeling full earlier in a meal and thinking about food less between meals.
The strength of that effect differs from person to person, and it is not a substitute for the eating and activity changes discussed at your consultation. No specific amount of weight change is promised or predicted here.
Written conditionally on purpose. These are areas the treatment may support in suitable patients, depending on clinical assessment — not outcomes you should expect.
This is not a self-assessment tool and it cannot tell you whether you are eligible. Eligibility depends on your medical history, current medications and a clinical assessment.
A licensed clinician reviews your health history, current medicines, previous weight-management attempts and what you are hoping to address.
Relevant measurements and, where indicated, baseline investigations. This is where suitability is genuinely determined — not on this website.
If treatment is appropriate, the clinician explains what it involves, the realistic range of outcomes, the possible side effects and the alternatives, so you can decide.
Scheduled reviews to check tolerance and progress, adjust the plan, and stop or change course if the treatment is not working for you.
Wegovy is a prescription-only medicine. It cannot be supplied on request, purchased through this website, or started without an assessment by a licensed prescriber.
Treatment here always begins with an assessment by a licensed healthcare professional. Nothing on this website establishes that a treatment is suitable for you, and selecting a treatment does not create a prescription.
Contraindications, drug interactions and your personal and family medical history must be reviewed by a clinician before any injection is considered. Some conditions, medicines, pregnancy and breastfeeding make certain treatments unsuitable.
Side effects vary by treatment and by person, and they are discussed with you individually before you decide. Individual responses vary, and no outcome can be promised.
This website does not provide diagnosis, emergency advice or a prescribing service. If you feel unwell or have urgent symptoms, contact a doctor or your local emergency service.
Yes. It is prescription-only, so a licensed clinician must assess your medical history, current medicines and suitability before any decision is made. That assessment cannot be replaced by an online form.
They share an active ingredient but are distinct products with different presentations and registered uses. They are not interchangeable, and choosing between them, or neither, is a clinical decision rather than a preference you select.
That is decided clinically and reviewed at each follow-up. It depends on how you respond, how well you tolerate it, and what you and the clinician agree the plan is working towards. There is no fixed course set in advance of assessing you.
Weight regain after stopping is well recognised with this class of medicine, which is why follow-up and a longer-term plan for nutrition and activity are discussed from the start rather than at the end.
Yes. You can select more than one treatment and send them as a single consultation request. Selecting several does not mean several will be recommended — the clinician will discuss which, if any, are appropriate.
Tirzepatide
A prescription medicine containing tirzepatide, which acts on two gut-hormone receptors involved in appetite and blood-sugar regulation. Suitability, dose and monitoring are decided by a clinician.
Consultation required · Prescription only
Aqualyx
An injectable treatment discussed for small, discrete pockets of fat in a defined area. It is a contouring treatment, not a weight-management medicine, and is assessed area by area.
Consultation required
